Teladoc Health (NYSE:TDOC - Free Report) had its target price trimmed by Citigroup from $11.00 to $8.75 in a research report report published on Friday morning,Benzinga reports. The firm currently has a neutral rating on the health services provider's stock.
TDOC has been the topic of a number of other research reports. Oppenheimer lowered their price objective on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research note on Friday, January 24th. Jefferies Financial Group cut their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a research note on Thursday, February 27th. Bank of America reduced their target price on shares of Teladoc Health from $9.50 to $8.00 and set a "neutral" rating on the stock in a report on Friday, April 11th. Finally, Piper Sandler cut their target price on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. Eleven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat.com, Teladoc Health presently has an average rating of "Hold" and a consensus target price of $10.46.
Read Our Latest Stock Report on TDOC
Teladoc Health Stock Performance
TDOC stock traded down $0.14 during midday trading on Friday, reaching $7.19. 3,235,934 shares of the company's stock traded hands, compared to its average volume of 6,200,358. Teladoc Health has a 52-week low of $6.35 and a 52-week high of $15.21. The stock's 50-day moving average is $8.27 and its 200 day moving average is $9.54. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The stock has a market cap of $1.26 billion, a P/E ratio of -1.25 and a beta of 1.73.
Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. As a group, analysts anticipate that Teladoc Health will post -1.16 EPS for the current year.
Insider Buying and Selling
In other news, insider Adam C. Vandervoort sold 11,011 shares of the business's stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now owns 64,308 shares of the company's stock, valued at approximately $541,473.36. The trade was a 14.62 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.58% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Teladoc Health
A number of large investors have recently made changes to their positions in the business. Versant Capital Management Inc lifted its holdings in Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock valued at $29,000 after acquiring an additional 2,441 shares during the period. Smith Anglin Financial LLC acquired a new stake in shares of Teladoc Health in the fourth quarter worth approximately $108,000. Arkadios Wealth Advisors purchased a new stake in Teladoc Health during the 4th quarter valued at about $115,000. Nisa Investment Advisors LLC boosted its stake in Teladoc Health by 20,936.8% during the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider's stock worth $3,874,000 after buying an additional 424,180 shares during the last quarter. Finally, Westside Investment Management Inc. increased its stake in shares of Teladoc Health by 43.8% in the 4th quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider's stock worth $84,000 after acquiring an additional 2,800 shares during the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.
About Teladoc Health
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Stories
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
